Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-27

Clinical Trial Update: Sorafenib and Vinorelbine in Treating Women With Stage IV Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion and posting of results from a Phase 1/2 trial evaluating the combination of sorafenib and vinorelbine in women with stage I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sorafenib (Sorafenib)
  • Vinorelbine (Vinorelbine)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-02-27